-
Federal government scaled down drug-pricing reforms to keep pharmaceutical industry robust: Health Minister
The new regulations, which govern the Patented Medicine Prices Review Board, will lower pharmaceutical industry profits by $2.9 billion over a decade, rather than the $8.8 billion anticipated previously.